Between Dec 19, 2024 and Jan 2, 2025, datasets can be submitted to DRUM but will not be processed until after the break. Staff will not be available to answer email during this period, and will not be able to provide DOIs until after Jan 2. If you are in need of a DOI during this period, consider Dryad or OpenICPSR. Submission responses to the UDC may also be delayed during this time.

Browsing by Author "Hughes, Kevin"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Synthesis and Testing of MCT1 and MCT4 Inhibiting Compounds as Novel Cancer Therapeutics
    (2015) Hughes, Kevin
    Triple negative breast cancers (TNBCs) account for 10-20% of breast cancers and generally affect younger patient populations (<50 years) as well as African-American/Hispanic women.1,2 Current treatment options consist of surgical resection and radiation/chemical therapy; however, many of the drugs used are not cancer cell specific and result in widespread toxicity throughout body systems. A number of novel, small organic molecules selective towards cancer cells by inhibition of monocarboxylate transporters (MCT) were developed under the direction of Dr. Venkatram Mereddy. These compounds analogous to Alpha-cyano-4-hydroxycinnamic acid (CHC, a known MCT inhibitor) were synthesized from readily-available reagents and show high potential as lead compounds based on in vitro and in vivo studies.